Alnylam Pharmaceuticals, Inc. is listed in the United States. Sector: Healthcare. Industry: Biotechnology.
Alnylam Pharmaceuticals, Inc. (ALNY): research close 156.50 USD on 2026-11-17. 52-week range 151.64 to 473.29 USD. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 156.50 USD | 2026-11-17 |
| Previous research close | 159.73 USD | 2026-11-16 |
| Change between the two dated research closes | -2.02% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 21.37 billion USD | 2026-11-16 |
| 52-week range of the research close | 151.64 – 473.29 USD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | -66.02% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 582.81 million USD | 2026-11-17 |
Source: us_closes_adjusted · US · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
Members can compare available company evidence and explicitly save ALNY to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate